216 related articles for article (PubMed ID: 19216903)
1. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.
Sarkar S; Ravikumar B; Rubinsztein DC
Methods Enzymol; 2009; 453():83-110. PubMed ID: 19216903
[TBL] [Abstract][Full Text] [Related]
2. Small molecule enhancers of autophagy for neurodegenerative diseases.
Sarkar S; Rubinsztein DC
Mol Biosyst; 2008 Sep; 4(9):895-901. PubMed ID: 18704227
[TBL] [Abstract][Full Text] [Related]
3. Huntington's disease: degradation of mutant huntingtin by autophagy.
Sarkar S; Rubinsztein DC
FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.
Sarkar S; Ravikumar B; Floto RA; Rubinsztein DC
Cell Death Differ; 2009 Jan; 16(1):46-56. PubMed ID: 18636076
[TBL] [Abstract][Full Text] [Related]
5. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in neurodegeneration and development.
Winslow AR; Rubinsztein DC
Biochim Biophys Acta; 2008 Dec; 1782(12):723-9. PubMed ID: 18644437
[TBL] [Abstract][Full Text] [Related]
7. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Williams A; Sarkar S; Cuddon P; Ttofi EK; Saiki S; Siddiqi FH; Jahreiss L; Fleming A; Pask D; Goldsmith P; O'Kane CJ; Floto RA; Rubinsztein DC
Nat Chem Biol; 2008 May; 4(5):295-305. PubMed ID: 18391949
[TBL] [Abstract][Full Text] [Related]
8. Assessing Autophagic Activity and Aggregate Formation of Mutant Huntingtin in Mammalian Cells.
Stamatakou E; Zhu Y; Rubinsztein DC
Methods Mol Biol; 2018; 1780():17-29. PubMed ID: 29856012
[TBL] [Abstract][Full Text] [Related]
9. Clearance of mutant aggregate-prone proteins by autophagy.
Ravikumar B; Sarkar S; Rubinsztein DC
Methods Mol Biol; 2008; 445():195-211. PubMed ID: 18425452
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
[TBL] [Abstract][Full Text] [Related]
11. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.
Ravikumar B; Duden R; Rubinsztein DC
Hum Mol Genet; 2002 May; 11(9):1107-17. PubMed ID: 11978769
[TBL] [Abstract][Full Text] [Related]
12. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
Ravikumar B; Rubinsztein DC
Mol Aspects Med; 2006; 27(5-6):520-7. PubMed ID: 16973207
[TBL] [Abstract][Full Text] [Related]
13. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
Sarkar S
Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
[TBL] [Abstract][Full Text] [Related]
14. Lithium induces autophagy by inhibiting inositol monophosphatase.
Sarkar S; Floto RA; Berger Z; Imarisio S; Cordenier A; Pasco M; Cook LJ; Rubinsztein DC
J Cell Biol; 2005 Sep; 170(7):1101-11. PubMed ID: 16186256
[TBL] [Abstract][Full Text] [Related]
15. Chemical screening platforms for autophagy drug discovery to identify therapeutic candidates for Huntington's disease and other neurodegenerative disorders.
Sarkar S
Drug Discov Today Technol; 2013; 10(1):e137-44. PubMed ID: 24050242
[TBL] [Abstract][Full Text] [Related]
16. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.
Sarkar S; Krishna G; Imarisio S; Saiki S; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2008 Jan; 17(2):170-8. PubMed ID: 17921520
[TBL] [Abstract][Full Text] [Related]
17. Complex inhibitory effects of nitric oxide on autophagy.
Sarkar S; Korolchuk VI; Renna M; Imarisio S; Fleming A; Williams A; Garcia-Arencibia M; Rose C; Luo S; Underwood BR; Kroemer G; O'Kane CJ; Rubinsztein DC
Mol Cell; 2011 Jul; 43(1):19-32. PubMed ID: 21726807
[TBL] [Abstract][Full Text] [Related]
18. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.
Menzies FM; Fleming A; Caricasole A; Bento CF; Andrews SP; Ashkenazi A; Füllgrabe J; Jackson A; Jimenez Sanchez M; Karabiyik C; Licitra F; Lopez Ramirez A; Pavel M; Puri C; Renna M; Ricketts T; Schlotawa L; Vicinanza M; Won H; Zhu Y; Skidmore J; Rubinsztein DC
Neuron; 2017 Mar; 93(5):1015-1034. PubMed ID: 28279350
[TBL] [Abstract][Full Text] [Related]
19. Variations in the effects on synthesis of amyloid beta protein in modulated autophagic conditions.
Makioka K; Yamazaki T; Kakuda S; Okamoto K
Neurol Res; 2009 Nov; 31(9):959-68. PubMed ID: 19215663
[TBL] [Abstract][Full Text] [Related]
20. Atg4b-dependent autophagic flux alleviates Huntington's disease progression.
Proenca CC; Stoehr N; Bernhard M; Seger S; Genoud C; Roscic A; Paganetti P; Liu S; Murphy LO; Kuhn R; Bouwmeester T; Galimberti I
PLoS One; 2013; 8(7):e68357. PubMed ID: 23861892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
